Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05928208
Other study ID # 82/03.03.2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2017
Est. completion date May 30, 2023

Study information

Verified date June 2023
Source Universitatea de Medicina si Farmacie Iuliu Hatieganu
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study compares a device that is used for the detection of bacteria and MDR pathogens from skin, soft tissue and nose with the gold-standard (microbiological lab). It is a novel use for this device because it has been used in samples from the lower-respiratory tract.


Description:

The purpose of this study is to find out if a POC-PCR device can be use in the diagnosis of hospital acquired pneumonia and ventilation-associated pneumonia.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 30, 2023
Est. primary completion date May 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients that are admitted for at least 48 hours - radiological findings typical for pneumonia - signs of infection Exclusion Criteria: - patient or patient relatives doesn't accept to enter the study

Study Design


Intervention

Diagnostic Test:
no intervention
no intervention

Locations

Country Name City State
Romania Spitalul Clinic Judetean de Urgenta Cluj Cluj-Napoca Cluj

Sponsors (1)

Lead Sponsor Collaborator
Universitatea de Medicina si Farmacie Iuliu Hatieganu

Country where clinical trial is conducted

Romania, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the sensibility and specificity of the device GeneXpert in diagnosis of pneumonia Comparison between device and gold standard 4 years
Primary Utility of POC-PCR in managing pneumonia Decision making in pneumonia management 4 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04488510 - Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Completed NCT02598609 - SEPREVEN: a Stepped-wedge Randomised Controlled Trial N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT06162455 - High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB N/A
Terminated NCT01897792 - Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma Phase 2
Completed NCT01363271 - Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients Phase 4
Recruiting NCT00842478 - Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia Phase 2/Phase 3
Completed NCT00610324 - Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients Phase 4
Completed NCT04279873 - Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
Completed NCT03303937 - Characteristics of Lower Respiratory Tract Escherichia Coli Isolates in Mechanically Ventilated Intensive Care Patients N/A
Recruiting NCT01796717 - Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia Phase 2/Phase 3
Recruiting NCT06170372 - High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia N/A
Completed NCT00829842 - Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart Surgery Phase 3
Recruiting NCT06261827 - High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB N/A
Completed NCT02793141 - International Study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE)
Completed NCT00236834 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization Phase 3
Not yet recruiting NCT06310941 - Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection N/A
Completed NCT02413242 - Advanced Understanding of Staphylococcus Aureus and Pseudomonas Aeruginosa Infections in EuRopE - ICU
Recruiting NCT04223752 - Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036) Phase 1